Compare ELVN & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | ACDC |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | 61 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.1B |
| IPO Year | 2020 | 2021 |
| Metric | ELVN | ACDC |
|---|---|---|
| Price | $34.61 | $6.84 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.40 | $5.50 |
| AVG Volume (30 Days) | 684.5K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,941,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.79 | $3.08 |
| 52 Week High | $48.53 | $10.70 |
| Indicator | ELVN | ACDC |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 48.83 |
| Support Level | $25.63 | $5.82 |
| Resistance Level | $40.62 | $7.85 |
| Average True Range (ATR) | 2.02 | 0.61 |
| MACD | -0.84 | 0.00 |
| Stochastic Oscillator | 4.80 | 44.16 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.